Biotechnology in India II

1. Front Matter

   Pages I-XIII

   PDF

2. Bioethanol in India: Recent Past and Emerging Future

   • Purnendu Ghosh, Tarun K. Ghose

   Pages 1-27

3. Commercialization of a Novel Fermentation Concept

   • Kiran Mazumdar-Shaw, Shrikumar Suryanarayan

   Pages 29-42

4. Bioprocessing of Therapeutic Proteins from the Inclusion Bodies of Escherichia coli

   • Amulya K. Panda

   Pages 43-93

5. Research and Application of Microbial Enzymes — India’s Contribution

   • Subhash Chand, Prashant Mishra

   Pages 95-124

6. Molecular Mechanisms of Energy Transduction in Cells: Engineering Applications and Biological Implications

   • Sunil Nath

   Pages 125-180

7. Status of Immunodiagnosis and Immunocontraceptive Vaccines in India

   • S. K. Gupta

   Pages 181-214

8. Medical Biotechnology in India

   • Braj B. Lohray

   Pages 215-281

9. Back Matter

   Pages 283-304

   PDF

The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD 1 billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining 25% of which the diagnostics share was about 10% of the total surely presented an encouraging picture even five years ago. While volumes have increased, the pat tern has not. According to a report, prepared by McKinsey & Co, India's Phar maceutical industry including domestic and export sales and contract services totals nearly USD 5 billion. Furthermore, the company optimistically projects the growth to a factor of five fold only if both the industry and the government are able to put in place achievable solutions that must take care of the formida ble obstacles preventing further growth. If this assessment is correct, then the established transformation made by IT growth should also provide the confi dence required by the high expectations for biotechnology which have arisen in the country in recent years. Some contributors to this are overenthusiastic these are bureaucrats, some retired scientists and of course the complacent politicians who have the least knowledge of what the new biotechnology is all about. However, there are clear indications of biotechnology growth demon strated by a few but rapidly expanding biotech companies such as Biocon Ltd, Shantha Biotech (P) Ltd, Dr.

• Fermentation
• Medical Biotechnology
• biochemical engineering
• biochemistry
• biotechnology
• chemical engineering
• chemistry
• enzymes
• protein

• 281 SFS Apartments, New Delhi, India

  Tarun K. Ghose

• Birla Institute of Scientific Research, Jaipur, India

  Purnendu Ghosh

Policies and ethics